
Basic Protective Measures Against COVID-19
COVID-19 is a new strain of the common cold that has been p...
COVID-19 is a new strain of the common cold that has been p...
Ranibizumab is used for the treatment of certain serious eye conditions such as:
This is for people with sight problems that are caused by conditions where blood vessels leak into an area at the back of the eye. This medication helps to slow the growth of abnormal new blood vessels in the eye.
Ranibizumab is a monoclonal antibody that binds to vascular endothelial growth factor A (VEGF-A). By binding to VEGF-A, this medicine blocks the action of this substance. In which it stops the growth of blood vessels in the eye. Ranibizumab may help improve damaged vision or prevent it from getting worse.
In certain eye conditions, blood vessels from the back of the eye grow in an abnormal fashion into the macula. These blood vessels may bleed or leak into this area. It may cause swelling and a rapid reduction in central vision. The substance VEGF-A is responsible for making the blood vessels grow and leak.
Ranibizumab is a type of medicine called a vascular endothelial growth factor (VEGF) inhibitor. It helps lessen the leakage from the blood vessels that may cause vision loss. This medicine is a sterile, colorless to pale yellow solution in a single-use glass vial. The vial comes in two forms:
0.3 mg and 0.5 mg dose vial for intraocular use. Ranibizumab is supplied as a preservative-free and sterile solution in a single-use container. This prescription is approved by the Food and Drug Administration (FDA).
The recommended dosage is based on your medical condition and response. It is very important that you take this prescription exactly as it is given. This is to be given by injection into the affected eyes by a doctor or healthcare professional. Before each injection, the affected eye is numbed and your eye will be monitored. After the injection, you will remain in the doctor’s room for a while so your eye will be monitored.